[HTML][HTML] Molecular modeling in drug discovery

TI Adelusi, AQK Oyedele, ID Boyenle… - Informatics in Medicine …, 2022 - Elsevier
With the financial requirements and high time associated with bringing a commercial drug to
the market, the application of computer-aided drug design has been recognized as a …

Yes SIR! On the structure–inactivity relationships in drug discovery

E López-López, E Fernández-de Gortari… - Drug Discovery …, 2022 - Elsevier
Highlights•Inactivity data is helpful.•Structure-Inactivity Relationships (SIRs) are valuable in
drug discovery.•Machine and deep learning benefit from SIRs.•The inactivity data gap in the …

TB-IECS: an accurate machine learning-based scoring function for virtual screening

X Zhang, C Shen, D Jiang, J Zhang, Q Ye, L Xu… - Journal of …, 2023 - Springer
Abstract Machine learning-based scoring functions (MLSFs) have shown potential for
improving virtual screening capabilities over classical scoring functions (SFs). Due to the …

Carboxylesterase 1 and precision pharmacotherapy: pharmacogenetics and nongenetic regulators

L Her, HJ Zhu - Drug Metabolism and Disposition, 2020 - ASPET
Carboxylesterase (CES) 1 is the most abundant drug-metabolizing enzyme in human livers,
comprising approximately 1% of the entire liver proteome. CES1 is responsible for 80 …

Green pathway for utilisation of orange peel dust and in silico evaluation of pharmacological potential

S Krivošija, I Jerković, N Nastić, M Zloh, S Jokić… - Microchemical …, 2023 - Elsevier
This study is focused on the investigation of the new ways of valorization and maximal
utilisation of the fruit dust obtained from the orange peel during industrial processing in the …

Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2

YQ Song, RJ He, D Pu, XQ Guan, JH Shi… - Frontiers in …, 2021 - frontiersin.org
Human carboxylesterase 2 (CES2), one of the most abundant hydrolases distributed in the
small intestine, has been validated as a key therapeutic target to ameliorate the intestinal …

No dance, no partner! A tale of receptor flexibility in docking and virtual screening

A Basciu, L Callea, S Motta, AMJJ Bonvin… - Annual Reports in …, 2022 - Elsevier
Modern drug design relies on a detailed understanding of the molecular recognition process
by which biological partners such as a protein and a drug interact and bind to each other …

[HTML][HTML] Identification of Riluzole derivatives as novel calmodulin inhibitors with neuroprotective activity by a joint synthesis, biosensor, and computational guided …

M Baltasar-Marchueta, L Llona, M Sara… - Biomedicine & …, 2024 - Elsevier
The development of new molecules for the treatment of calmodulin related cardiovascular or
neurodegenerative diseases is an interesting goal. In this work, we introduce a novel …

Carboxylesterase 1 and Precision Pharmacotherapy

L Her - 2021 - deepblue.lib.umich.edu
Carboxylesterase 1 (CES1) is a major phase I drug-metabolizing enzyme, responsible for 80-
95% of total hydrolytic activity in human livers. CES1 plays a crucial role in the metabolism of …

[PDF][PDF] Informatics in Medicine Unlocked

TI Adelusi, AQK Oyedele, ID Boyenle, AT Ogunlana… - researchgate.net
With the financial requirements and high time associated with bringing a commercial drug to
the market, the application of computer-aided drug design has been recognized as a …